Soler_2019_BMC.Geriatr_19_101

Reference

Title : Continuation versus discontinuation of treatment for severe dementia: randomized, pragmatic, open-label, clinical trial to evaluate the efficacy of continuing drug treatment in patients with severe dementia (STOP-DEM) - Soler_2019_BMC.Geriatr_19_101
Author(s) : Soler A , Amer G , Leiva A , Ripoll J , Llorente MA , Taltavull JM , Molina R , Llobera J
Ref : BMC Geriatr , 19 :101 , 2019
Abstract : Soler_2019_BMC.Geriatr_19_101
ESTHER : Soler_2019_BMC.Geriatr_19_101
PubMedSearch : Soler_2019_BMC.Geriatr_19_101
PubMedID: 30971215

Related information

Citations formats

Soler A, Amer G, Leiva A, Ripoll J, Llorente MA, Taltavull JM, Molina R, Llobera J (2019)
Continuation versus discontinuation of treatment for severe dementia: randomized, pragmatic, open-label, clinical trial to evaluate the efficacy of continuing drug treatment in patients with severe dementia (STOP-DEM)
BMC Geriatr 19 :101

Soler A, Amer G, Leiva A, Ripoll J, Llorente MA, Taltavull JM, Molina R, Llobera J (2019)
BMC Geriatr 19 :101